These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8063518)

  • 1. Weak magnetic fields antagonize the effects of melatonin on blood glucose levels in Parkinson's disease.
    Sandyk R
    Int J Neurosci; 1993 Jan; 68(1-2):85-91. PubMed ID: 8063518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone attenuates the antiparkinsonian effects of picoTesla range magnetic fields.
    Sandyk R; Iacono RP
    Int J Neurosci; 1994 Sep; 78(1-2):111-22. PubMed ID: 7829285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weak magnetic fields in the treatment of Parkinson's disease with the "on-off" phenomenon.
    Sandyk R
    Int J Neurosci; 1992 Sep; 66(1-2):97-106. PubMed ID: 1304575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of micrographia in Parkinson's disease by application of picoTesla range magnetic fields.
    Sandyk R; Iacono RP
    Int J Neurosci; 1994 Jul; 77(1-2):77-84. PubMed ID: 7989163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of external picoTesla range magnetic fields on the EEG in Parkinson's disease.
    Sandyk R; Derpapas K
    Int J Neurosci; 1993 May; 70(1-2):85-96. PubMed ID: 8083028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic fields in the treatment of Parkinson's disease.
    Sandyk R; Anninos PA; Tsagas N; Derpapas K
    Int J Neurosci; 1992 Mar; 63(1-2):141-50. PubMed ID: 1342026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonian micrographia reversed by treatment with weak electromagnetic fields.
    Sandyk R
    Int J Neurosci; 1995 Mar; 81(1-2):83-93. PubMed ID: 7775074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Parkinson's disease with magnetic fields reduces the requirement for antiparkinsonian medications.
    Sandyk R
    Int J Neurosci; 1994; 74(1-4):191-201. PubMed ID: 7928105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pineal-hypothalamic tract mediation of picotesla magnetic fields in the treatment of neurological disorders.
    Jacobson JI
    Panminerva Med; 1994 Dec; 36(4):201-5. PubMed ID: 7603740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of ECT in Parkinson's disease: possible role of pineal melatonin.
    Sandyk R
    Int J Neurosci; 1990 Jan; 50(1-2):83-94. PubMed ID: 2269603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further observations on the unique efficacy of picoTesla range magnetic fields in Parkinson's disease.
    Sandyk R; Derpapas K
    Int J Neurosci; 1993; 69(1-4):167-83. PubMed ID: 8083004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in word-fluency performance in Parkinson's disease by administration of electromagnetic fields.
    Sandyk R
    Int J Neurosci; 1994 Jul; 77(1-2):23-46. PubMed ID: 7989159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid improvement of visuoperceptive functions by picoTesla range magnetic fields in patients with Parkinson's disease.
    Sandyk R; Iacono RP
    Int J Neurosci; 1993 Jun; 70(3-4):233-54. PubMed ID: 8063543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pineal melatonin and sensory symptoms in Parkinson disease.
    Sandyk R
    Ital J Neurol Sci; 1989 Aug; 10(4):399-403. PubMed ID: 2676905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct suppressive effects of weak magnetic fields (50 Hz and 16 2/3 Hz) on melatonin synthesis in the pineal gland of Djungarian hamsters (Phodopus sungorus).
    Brendel H; Niehaus M; Lerchl A
    J Pineal Res; 2000 Nov; 29(4):228-33. PubMed ID: 11068945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pineal melatonin level disruption in humans due to electromagnetic fields and ICNIRP limits.
    Halgamuge MN
    Radiat Prot Dosimetry; 2013 May; 154(4):405-16. PubMed ID: 23051584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pineal melatonin functions: possible relevance to Parkinson's disease.
    Sandyk R
    Int J Neurosci; 1990 Jan; 50(1-2):37-53. PubMed ID: 2269599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the pineal gland on migraine and cluster headaches and effects of treatment with picoTesla magnetic fields.
    Sandyk R
    Int J Neurosci; 1992; 67(1-4):145-71. PubMed ID: 1305631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electromagnetic fields and melatonin production.
    Reiter RJ
    Biomed Pharmacother; 1993; 47(10):439-44. PubMed ID: 8061243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic fields and pineal function in humans: evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms.
    Selmaoui B; Lambrozo J; Touitou Y
    Life Sci; 1996; 58(18):1539-49. PubMed ID: 8649183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.